This site uses technical and analytics cookies.
By continuing to browse, you agree to the use of cookies.

Massimo Alberti (REVIVO) and Michelle Hong (Menarini) awarded in Italy by the Minister of University and Research

Foto consegna premiazione

At the National Conference of Science and Space Attachés and Agricultural Experts in Turin, the Minister of University and Research (MUR), Anna Maria Bernini, in the presence of the Vice President of the Council of Ministers and Minister of Foreign Affairs and International Cooperation, Antonio Tajani, presented on April 23, 2024 two prestigious awards  to Massimo Alberti and Michelle Hong who do high-tech research and development in Singapore.

Massimo Alberti received the “Innovation that speaks Italian” award in recognition of the high innovative value of Technological Startups operating abroad and founded by Italian citizens. This is the first time that such an award, now in its sixth edition, has been given to a startupper residing in Asia. Massimo Alberti is CEO of REVIVO BioSystems, a company that specializes in combining microfluidics, tissue engineering and proteomics to create organ-on-chip devices that replicate human tissue in the laboratory. Under him, REVIVO BioSystems has launched the first dynamic 4D in vitro model platform, providing accurate preclinical data for the cosmetic, nutraceutical, and pharmaceutical industries; fostered business growth with global partnerships; recruited and led a team of more than 10 engineers, scientists, and commercial experts; and won accolades for its innovative work in reducing animal testing. Born in Ascoli Piceno, Italy, he studied Biomedical Engineering at Politecnico di Milano. Arriving in Singapore in 2014, as a Research Fellow and Scientist at the Agency for Science, Technology and Research (A*STAR) he developed and patented organ-on-chip technologies and further matured his entrepreneurial spirit culminating in REVIVO BioSystems, which he founded over 5 years ago.

Michelle Hong received the “Science, She Says! Award,” for the Asia-Pacific region, which recognizes a brilliant young woman foreign scientist who has contributed greatly to the advancement of science and technology in collaboration with Italian researchers and institutions. Michelle Hong is currently R&D Scientific Manager at A. Menarini Biomarkers Singapore where she leads a research group on non-invasive single-cell precision diagnostics in oncology and prenatal medicine and where she coordinates all validation procedures of several clinical trials. She had received her BSc in 2007 and later her PhD in Immunology in 2011 from NUS. After her Ph.D. she was a Research Fellow until 2020 at Duke-NUS Medical School working in Prof Antonio Bertoletti’s group and doing research in multiple fields from oncology to immunology and infectious diseases. She was awarded, among others, a $250,000 Singapore Grant to characterize antigen-specific and global immune responses in patients with chronic hepatitis B virus infection. She has published numerous scientific papers in leading journals, particularly in Nature Communication and Gastroenterology as first author, and received numerous awards already.

Last year, on March 6, 2023 in Padua, it was Prof Dario Campana of the National University of Singapore who had received from Minister Tajani, the Italian Bilateral Cooperation Award that Farnesina dedicates every year to the most prestigious Italian researchers working and living abroad. These three awards, which are all those that MAECI dedicates to researchers abroad, demonstrate the excellence of Italian research in Singapore and the excellent integration of the Italian scientific community with Italian and local institutions in the S&T field.